ClearPoint Neuro Inc. (CLPT)
| Market Cap | 295.22M |
| Revenue (ttm) | 12.32M |
| Net Income (ttm) | -6.85M |
| Shares Out | 15.72M |
| EPS (ttm) | -0.43 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $17.50 |
| Previous Close | $15.76 |
| Change ($) | 1.74 |
| Change (%) | 11.04% |
| Day's Open | 16.69 |
| Day's Range | 15.30 - 17.99 |
| Day's Volume | 451,971 |
| 52-Week Range | 3.08 - 17.99 |
IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today report...
IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the bra...
Represents Draw of Additional Proceeds from Petrichor Announced in January 2020 Represents Draw of Additional Proceeds from Petrichor Announced in January 2020
IRVINE, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a leader in image-guided stereotactic neurosurgery, announced that its 4,000th neurosurgical procedure ...
IRVINE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a medical device company with a portfolio of products focused on enabling therapies for neurological di...
About CLPT
ClearPoint Neuro operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline inc... [Read more...]
| Industry Medical Devices | Founded 1998 |
| Stock Exchange NASDAQ | Ticker Symbol CLPT |
Financial Performance
In 2019, CLPT's revenue was $11.22 million, an increase of 52.54% compared to the previous year's $7.35 million. Losses were -$5.54 million, -10.12% less than in 2018.
Analyst Forecasts
According to one analyst, the rating for CLPT stock is "Strong Buy" and the 12-month stock price forecast is 18.00.